Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (37)

« Back to Publications

Human studies of cannabinoids and medicinal cannabis

Robson PJ., (2018)

Preliminary clinical and pharmacokinetic experiences in the newborn when meptazinol is compared with pethidine as an obstetric analgesic

Robson PJ. and Jackson MBA., (2018), Postgraduate Medical Journal

A comparison of the respiratory effects of meptazinol, pentazocine and morphine.

Robson PJ. et al, (2018), British Journal of Anaesthesia

Treatment of chronic pain by the use of meptazinol administered into the epidural space.

Robson PJ. et al, (2018), Postgraduate Medical Journal

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

McGuire P. et al, (2018), Am J Psychiatry, 175, 225 - 231

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Devinsky O. et al, (2014), Epilepsia, 55, 791 - 802

Cannabinoids and schizophrenia: therapeutic prospects.

Robson PJ. et al, (2014), Curr Pharm Des, 20, 2194 - 2204

Therapeutic potential of cannabinoid medicines.

Robson PJ., (2014), Drug Test Anal, 6, 24 - 30

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.

Robson P., (2011), Expert Opin Drug Saf, 10, 675 - 685

Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine

Russo EB. et al, (2007), ChemInform, 38

The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults.

Rogers RD. et al, (2007), Neuropsychopharmacology, 32, 417 - 428

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis.

Wade DT. et al, (2006), Mult Scler, 12, 639 - 645

Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.

Tomida I. et al, (2006), J Glaucoma, 15, 349 - 353

Low doses of delta-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults.

Makela P. et al, (2006), Neuropsychopharmacology, 31, 462 - 470

Safety and tolerability of long-term treatment with a cannabis-based medicine (SATIVEX) in patients with rheumatoid arthritis

Blake DR. et al, (2006), ANNALS OF THE RHEUMATIC DISEASES, 65, 498 - 498

Load More